Sport & Auto
- About Future
- Digital Future
- Cookies Policy
- Terms & Conditions
- Investor Relations
- Contact Future
Take a gander at a wealth of Italian machines from the halls of Eurobike
BMC shows off design and manufacturing capability with project bike
Tejay van Garderen's BMC, Alex Howes' Cervelo, and more
Custom front end for fast and flowy handling
After struggling at the start of the final climb, Frank Schleck rallied to finish 12th
UCI confirm remaining tests all negative
The UCI has announced that the Tour de France returned no additional positive anti-doping controls upon completion of the analyses.
“The Cycling Anti-Doping Foundation (CADF) has received the complete and final results of the last tests carried out at the Tour de France 2012. The samples received from the Châtenay-Malabry, Lausanne and Cologne laboratories all showed a negative result,” cycling’s governing body said in a press release.
However the news comes after Frank Schleck (RadioShack-Nissan) returned a positive sample at the Tour de France after stage 13. The 32-year-old was found to have traces of a diuretic, Xipamid, in his system.
The substance is banned by WADA and Schleck later denied taking the substance, which can be used as a masking agent. His B sample later returned the same findings and the Luxembourg Anti-Doping Agency (ALAD) sent Fränk Schleck's case to its disciplinary committee, where it still sits.